Differential effects of topiramate in patients with traumatic brain injury and obesity - A case series

Psychopharmacology

Volumn 179, Issue 4, 2005, Pages 838-845

  Dolberg, Ornah T ^a,d   Barkai, Gaby ^a   Gross, Yigal ^b,c   Schreiber, Shaul ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Neuropsychological Unit for Treatment and Rehabilitation   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

^d H LUNDBECK A S   (Denmark)

Author keywords

Binge eating disorder; Epilepsy; Obesity; Post Traumatic Stress Disorder; PTSD; Side effects; TBI; Topiramate; Traumatic brain injury; Weight gain

Indexed keywords

BROTIZOLAM; CARBAMAZEPINE; CITALOPRAM; CLONAZEPAM; DIAZEPAM; ETODOLAC; FLUNITRAZEPAM; FLUOXETINE; LEVOTHYROXINE SODIUM; LITHIUM; LORAZEPAM; MIRTAZAPINE; OLANZAPINE; PAROXETINE; REBOXETINE; RISPERIDONE; ROFECOXIB; SERTRALINE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE; ZOPICLONE;

ADULT; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EPILEPSY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; MALE; OBESITY; PARESTHESIA; PRIORITY JOURNAL; SOMNOLENCE; WEIGHT GAIN;

ADULT; ANTICONVULSANTS; BODY WEIGHT; BRAIN INJURIES; BULIMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEEDING BEHAVIOR; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; OBESITY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS;

EID: 20044385786     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2117-y     Document Type: Article

References (21)

1. Appolinario JC, Fontenelle LF, Papelbaum M, Bueno JR, Coutinho W (2002) Topiramate use in obese patients with binge eating disorder: an open study. Can J Psychiatry 47:271-273
2. Birt, J (2003) Management of weight gain associated with antipsychotics. Ann Clin Psychiatry 15:49-58
3. Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, Perry BH (2003) A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 11:722-733
4. Calabrese JR, Keck PE, McElroy SL, Shelton MD (2001) A pilot study of topiramate as monotherapy in the treatment of acute mania. J Clin Psychopharmacol 21:340-342
5. Carpenter LL, Leon Z, Yasmin S, Price LH (2002) Do obese depressed patients respond to topiramate? A retrospective chart review. J Affect Disorder 69:251-255
6. Chengappa KNR, Gershon S, Levine J (2001a) The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder. Bipolar Disord 3:215-232
7. Chengappa KNR, Levine J, Rathore D, Parepally H, Atzert R (2001b) Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series. Eur Psychiatry 16:186-190
8. Colom F, Vieta E, Benabarre A, Reinares M, Corbella B, Gasto C (2001) Topiramate abuse in a bipolar patient with an eating disorder. J Clin Psychiatry 62:475-476
9. Dursun SM, Devarajan S (2000) Clozapine weight gain, plus topiramate weight loss. Can J Psychiatry 45:198
10. Dursun, SM, Devarajan S (2001) Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanism of action? Can J Psychiatry 46:50-51
11. Erfurth A, Kuhn G (2000) Topiramate monotherapy in the maintenance treatment of bipolar I disorder: effects on mood, weight and serum lipids. Neuropsychobiology 42:50-51
12. Gordon A, Price LH (1999) Mood stabilization and weight loss with topiramate. Am J Psychiatry 156:968-969
13. Lessig MC, Shapira NA, Murphy TK (2001) Topiramate for reversing atypical antipsychotic weight gain. J Am Acad Child Adolesc Psych 40:1364
14. McElroy, SL, Arnold LM, Shapira NA (2003) Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry 160:255-261
15. National Heart, Lung and Blood Institute (NHLBI) Obesity Task Force (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6:51-209
16. Shapira NA, Goldsmith TD, McElroy SL (2000) Treatment of binge-eating disorder with topiramate: a clinical case series. J Clin Psychiatry 61:368-372
17. Van Ameringen M, Mancini C, Pipe B, Campbell M, Oakman J (2002) Topiramate treatment for SSRI-induced weight gain in anxiety disorders. J Clin Psychiatry 63:981-984
18. Wallace SJ (2001) Newer antiepileptic drugs: advantages and disadvantages. Brain Dev 23:277-283
19. Weiden PJ, MacKell JA, McDonnell DD (2003) Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 66:51-57
20. Werneke U, Taylor D, Sanders TAB (2002) Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int Clin Psychopharmacol 17:145-160
21. Young WB, Hopkins MM, Shechter AL, Silberstein SD (2002) Topiramate: a case series in migraine prophylaxis. Cephalalgia 22:659-663